Rigorous test-negative design study with large real-world population (73,160 cases) over 15 years demonstrating vaccine effectiveness against the target pathogen with precise confidence intervals; not practice-changing because vaccination policy was already implemented.
This is a planned interventional mechanistic study with no results reported; it aims to characterize glucose metabolism in immune cells during critical illness using isotope tracing in a small ICU cohort.
This is an active clinical trial registry record with no posted results; the study design and planned endpoints are documented but outcome data are not yet reported.
A narrative review synthesizing current evidence on TB vaccine pipelines and preventive therapies, providing clinical and policy guidance rather than reporting primary efficacy data.